Literature DB >> 25914266

Aberrant lymphatic drainage and risk for melanoma recurrence after negative sentinel node biopsy in middle-aged and older men.

Anthony H Kaveh1, Nicole M Seminara1, Melynda A Barnes2, Aaron J Berger3, Frank W Chen1, Mike Yao1,2, Denise Johnson4, Sean Parsa4, Andrew Quon5, Susan M Swetter1,6, John B Sunwoo1,2.   

Abstract

BACKGROUND: Aberrant lymphatic drainage is believed to contribute to the high recurrence rate of head and neck melanomas. The purpose of this study was to identify the clinical significance of unexpected lymphatic drainage patterns.
METHODS: A single institution retrospective analysis was performed of middle-aged and older men (mean age, 66.2 years; range, 41-87 years) who underwent successful lymphoscintigraphy with sentinel lymph node biopsy (SLNB) from 1997 through 2012. Node status, distribution, and recurrence were assessed comparing patients with expected and unexpected drainage patterns.
RESULTS: Sixty-six patients were identified with 55.8 months median follow-up (range, 5.6-206.1 months). Unexpected sentinel lymph node drainage was associated with multiple basin drainage (p < .01) and greater recurrence after negative SLNB (p = .03). Both groups had similar anatomic distribution, sentinel lymph node sampling, histopathologic characteristics, follow-up, and survival.
CONCLUSION: Lymphatic drainage differing from expected patterns is associated with greater recurrence after negative SLNB in middle-aged and older men.
© 2015 Wiley Periodicals, Inc. Head Neck 38: E754-E760, 2016. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  discordant; head and neck melanoma; lymphatic drainage; negative sentinel node biopsy; recurrence

Mesh:

Year:  2015        PMID: 25914266     DOI: 10.1002/hed.24094

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  Sentinel lymph node biopsy in cutaneous head and neck melanoma.

Authors:  D Evrard; E Routier; C Mateus; G Tomasic; J Lombroso; F Kolb; C Robert; A Moya-Plana
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-19       Impact factor: 2.503

2.  Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients.

Authors:  Marloes Faut; Kevin P Wevers; Robert J van Ginkel; Gilles F H Diercks; Harald J Hoekstra; Schelto Kruijff; Lukas B Been; Barbara L van Leeuwen
Journal:  Ann Surg Oncol       Date:  2016-09-19       Impact factor: 5.344

3.  Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck.

Authors:  Brian R Gastman; Jonathan S Zager; Jane L Messina; Robert W Cook; Kyle R Covington; Brooke Middlebrook; Pedram Gerami; Jeffrey D Wayne; Sancy Leachman; John T Vetto
Journal:  Head Neck       Date:  2019-01-29       Impact factor: 3.147

4.  Advantages of Sentinel Lymph Node Mapping by Single Photon Emission Computed Tomography/Computed Tomography in Early-Stage Malignant Head-and-Neck Skin Tumors.

Authors:  Enrique Cadena-Pineros; Juliaìn Goìmez-Herrera; Melissa Mayo-Patiño; Alexander Carreño
Journal:  Indian J Nucl Med       Date:  2022-03-25

5.  Sentinel Lymph Node Biopsy in Head and Neck Melanoma: Long-term Outcomes, Prognostic Value, Accuracy, and Safety.

Authors:  John E Hanks; Kevin J Kovatch; S Ahmed Ali; Emily Roberts; Alison B Durham; Joshua D Smith; Carol R Bradford; Kelly M Malloy; Philip S Boonstra; Christopher D Lao; Scott A McLean
Journal:  Otolaryngol Head Neck Surg       Date:  2020-02-11       Impact factor: 3.497

6.  Tumour mutation status and melanoma recurrence following a negative sentinel lymph node biopsy.

Authors:  Nikki R Adler; Rory Wolfe; Grant A McArthur; John W Kelly; Andrew Haydon; Catriona A McLean; Victoria J Mar
Journal:  Br J Cancer       Date:  2018-05-14       Impact factor: 7.640

7.  The Lymphoscintigraphic Study of Unpredictable Head and Neck Cutaneous Melanoma Lymphatic Drainage.

Authors:  Valentina Lavelli; Cristina Ferrari; Giulia Santo; Corinna Altini; Andrea Ballini; Angela Sardaro; Margherita Fanelli; Antonio Rosario Pisani; Anna Giulia Nappi; Giuseppe Giudice; Giuseppe Rubini
Journal:  Biomedicines       Date:  2020-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.